Polaryx Therapeutics Inc (PLYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 5,143 | 4,621 |
| Other current assets | 27 | 0 |
| TOTAL | $5,170 | $5,001 |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $5,170 | $5,001 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 470 | 72 |
| Accrued Expenses | 44 | 87 |
| Other current liabilities | 91 | 130 |
| TOTAL | $605 | $289 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $605 | $289 |
| Shareholders' Equity | ||
| Common Shares | 5 | 4 |
| Retained earnings | -99,635 | -90,650 |
| TOTAL | $4,565 | $4,712 |
| Total Liabilities And Equity | $5,170 | $5,001 |